The Conversation (0)
Luminex Corporation Third Quarter Earnings Release Scheduled for October 30, 2017
Oct. 10, 2017 05:55AM PST
Data InvestingLuminex Corporation (NASDAQ: LMNX) today announced that it expects to report results for the third quarter ended September 30, 2017 on Monday, October 30, 2017. A press release announcing the results is scheduled for release after the close of trading on that date. Management will hold a conference call to discuss the operating highlights and …
Luminex Corporation (NASDAQ: LMNX) today announced that it expects to report results for the third quarter ended September 30, 2017 on Monday, October 30, 2017. A press release announcing the results is scheduled for release after the close of trading on that date.
Management will hold a conference call to discuss the operating highlights and financial results for the third quarter ended September 30, 2017 on October 30, 2017, at 4:30 p.m. Eastern time.
Management will hold a conference call to discuss the operating highlights and financial results for the third quarter ended September 30, 2017 on October 30, 2017, at 4:30 p.m. Eastern time.
The conference call will be webcast live and may be accessed at Luminex Corporation’s website at https://www.luminexcorp.com. Simply log on to the website, go to the About Luminex section and access the Investor Relations link. Please go to the website at least 15 minutes prior to the call to register, download and install any necessary audio/video software. If you are unable to participate during the live webcast, the call will be archived for six months on the website using the ‘replay’ link.
About Luminex Corporation
At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. We accelerate reliable answers while simplifying complexity and deliver certainty with a seamless experience. To learn more about Luminex, please visit us at www.luminexcorp.com.
Luminex Corporate Contact:
Harriss Currie, 512.219.8020
Sr. Vice President, Finance and CFO
hcurrie@luminexcorp.com
Luminex Investor Contact:
Matthew Scalo, 512.219.8020
Sr. Director, Investor Relations
mscalo@luminexcorp.com
View original content with multimedia:https://www.prnewswire.com/news-releases/luminex-corporation-third-quarter-earnings-release-scheduled-for-october-30-2017-300533245.html
SOURCE Luminex Corporation
About Luminex Corporation
At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. We accelerate reliable answers while simplifying complexity and deliver certainty with a seamless experience. To learn more about Luminex, please visit us at www.luminexcorp.com.
Luminex Corporate Contact:
Harriss Currie, 512.219.8020
Sr. Vice President, Finance and CFO
hcurrie@luminexcorp.com
Luminex Investor Contact:
Matthew Scalo, 512.219.8020
Sr. Director, Investor Relations
mscalo@luminexcorp.com
View original content with multimedia:https://www.prnewswire.com/news-releases/luminex-corporation-third-quarter-earnings-release-scheduled-for-october-30-2017-300533245.html
SOURCE Luminex Corporation